JNJ

Johnson & Johnson | Cotação de Ações

Última atualização17/04/2025, 17:00:02

PreçoUS$ 157,47

Variação (dia)US$ 3,56 (2.31%)▲

Min. 52 SemanasUS$ 140,68

Máx. 52 SemanasUS$ 169,99

Capitalização de mercado--

Endereço: One Johnson & Johnson Plaza, New Brunswick, NJ, 08933

Telefone: 732 524 0400

Funcionários: 138.100

Johnson & JohnsonJNJ

US$ 157,47

+ 3,562,3%

17/04/2025 17:00:02

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atualUS$ 157,47

Valor de mercado--

AberturaUS$ 148,81

Preço máximoUS$ 159,44

Preço mínimoUS$ 154,16

VolumeUS$ 8,9 mi

Fechamento anteriorUS$ 153,91

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Ações relacionadas

The Procter & Gamble Company

PG ▼0.63% | US$ 169,53

Pfizer Inc.

PFE ▲0.06% | US$ 26,62

Merck & Co., Inc.

MRK ▼0.17% | US$ 99,70

The Coca-Cola Company

KO ▼0.12% | US$ 62,45

Exxon Mobil Corporation

XOM ▼0.01% | US$ 106,48

Saiba mais sobre a brapi e nossa missão de fornecer informações confiáveis

Entenda a missão da brapi em fornecer informações estritamente informativas de fontes confiáveis. Valorizamos a transparência e a responsabilidade, incentivando investidores a buscar aconselhamento financeiro independente para decisões informadas.

Fique por dentro das últimas notícias do mundo financeiro em nosso Blog

Mantenha-se atualizado com as últimas notícias financeiras em nosso Blog. Publicamos artigos informativos e análises de especialistas para fornecer insights valiosos sobre o cenário financeiro em constante evolução.

Assine nossa newsletter para receber atualizações gratuitas por e-mail

Mantenha-se informado assinando nossa newsletter. Receba atualizações gratuitas por e-mail, incluindo rendimentos, novidades do mercado e insights valiosos. Estamos comprometidos em fornecer informações relevantes diretamente à sua caixa de entrada.